AEO offers a number of benefits and mental well-being resources to its associates:

• AEO Mobile Wallet
• COVID-19 FAQS

Flimp, our benefits communication vendor, has created a video and digital postcard to better understand COVID-19.

• English Digital Postcard
• Spanish Digital Postcard
• French Canadian Digital Postcard

• Cigna Medical and Mental Health Virtual Care
• Cigna Coronavirus Resource Center
• Cigna Telehealth Connection
• Mental Well-Being Resources for Medically Enrolled Associates
• Employee Assistance Programs – confidential programs including stress management and financial services
• EAP Tips on Coping with the Fear of Coronavirus
• EAP Webcasts – on-demand webinars addressing Coronavirus fears and concerns
• Cigna Happify
• Cigna iPrevail

• COVID Supplemental leave FAQ
• US PTO Policy Update
• CA COVID-19 Supplemental Paid Sick
• Colorado Workplace Public Health Rights

• FutureFuel – resource to assess student loan repayment options
• COVID-19 Community Resources
• Financial Resources for Health Emergencies
• All Flexible Spending Accounts – Enrollment Instructions
• All Flexible Spending Accounts – Cancel or Change Deduction Instructions
• Coronavirus and ID Theft EAP

COVID-19 Vaccine FAQs

Note: the answers to these FAQS are based on publicly-available information provided by federal, state, and local health agencies as of April 26, 2021. The information below is not intended to be medical advice and AEO encourages all associates to consult with their medical providers about any specific questions about their situation. Furthermore, there are additional questions related to cost and availability of the vaccine that we simply don’t have answers to yet. We are monitoring the situation closely and will update these FAQs as additional information becomes available to AEO.  

Will AEO require me to get the COVID-19 vaccine?

No. AEO encourages all associates to get the vaccine if they are able, but will not require associates to get the vaccine as a condition of employment.

How many vaccine options are there?

As of April 2021, there are three vaccines that are authorized and recommended for use in the United States: the Pfizer-BioNTech COVID-19 vaccine (“Pfizer vaccine”), the Moderna COVID-19 vaccine (“Moderna vaccine”), and the Janssen-Johnson & Johnson Vaccine (“J&J Vaccine”).

However, as of March 1, 2021, other vaccines from AstraZeneca and Novavax were in Phase 3 clinical trials in the United States.

Canada has authorized four COVID-19 vaccines: Pfizer; Moderna; J&J and AstraZeneca.

What’s going on with the J&J vaccine?

On April 25, 2021, the CDC and FDA recommended that use of the J&J vaccine resume, after a pause was announced on April 13, 2021. The CDC determined that the J&J’s vaccines known and potential benefits outweigh its known and potential risk.

The pause allowed the agencies review data and make an assessment related to a rare adverse event following vaccinations— blood clots with low platelets. The pause allowed CDC to communicate with healthcare providers and re-emphasize the importance of reporting severe events in people who have received this vaccine, as well as how to report such events. The pause also gave experts time to carefully review all available data and conduct a risk-benefit analysis around the use of this vaccine. In reviewing the data, the CDC determined that out of 8 millions+ doses of the J&J vaccine, there were 15 reports of women who got the J&J vaccine who later developed a blood clot condition called thrombosis with thrombocytopenia syndrome. These 15 women were between the ages of 18 and 59 years old.

The CDC and FDA have emphasized that these blood clots appear to be extremely rare. However, vaccine safety is of top priority for the federal government. The pause is out of an abundance of caution to allow both the CDC and FDA to investigate and analyze these cases and then make an assessment regarding their significance.

 

What do I need to know if I’ve received or am planning to receive the J&J vaccine?

Women younger than 50 years old should be aware of the rare but increased risk of blood clots with low platelets after receiving the J&J vaccine, and that this risk has not been seen with the Moderna or Pfizer vaccines.

If you are planning to or have already you’ve received the J&J vaccine, medical experts advise that it is very unlikely that you have an adverse event. However, you should contact your health care provider if you develop severe headache, abdominal pain, leg pain, or shortness of breath.

If you would like to report any side effects of the COVID-19 vaccine, please check out the CDC’s V-safe program here.

When can I get a COVID-19 vaccine?

As of April 19, 2021, all adults in the United States are eligible for a COVID-19 vaccine.

To schedule an appointment or learn more about the vaccine rollout in your state, contact your local health department.

• California
• Iowa
• Kansas
• New York
• Pennsylvania

You can also find a vaccine appointment through VaccineFinder.

Canada

For information about the COVID-19 vaccine rollout in Canada, please click here.

Check whether you’re eligible to schedule a vaccine appointment in Ontario here.

Do the COVID-19 vaccines contain the live COVID-19 virus?

No. There are two types of COVID-19 vaccines currently authorized in the United States and Canada: mRNA and viral vector vaccines.

The Pfizer and Moderna COVID-19 vaccines are messenger RNA or “mRNA” vaccine. mRNA vaccines do not contain the live virus. Instead, mRNA vaccines teach our cells how to make a protein— in this case just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies. You can read more from the CDC about how the COVID-19 mRNA vaccines work here.

The J&J vaccine is a viral vector vaccine. Viral vector vaccines use a modified version of a different virus (the vector) to deliver important instructions to our cells. The vector (not the virus that causes COVID-19, but a different, harmless virus) will enter a cell in our body and then use the cell’s machinery to produce a harmless piece of the virus that causes COVID-19. This piece is known as a spike protein and it is only found on the surface of the virus that causes COVID-19. The J&J vaccine uses a harmless adenovirus as its viral vector. You can read more from the CDC about how the COVID-19 viral vector vaccines work here.

The AstraZeneca COVID-19 vaccine authorized in Canada is also a viral vector vaccine.

 

I’m nervous about taking the COVID-19 vaccine because it seems like the vaccines were developed so quickly. What process was used to ensure the vaccines’ safety? 

The Food and Drug Administration (“FDA”)—the federal agency tasked with ensuring the safety and efficacy of drugs—issued an Emergency Use Authorization (“EUA”) for the Pfizer and Moderna COVID-19 vaccines in December 2020, and the Johnson & Johnson COVID-19 vaccine in February 2021. This means that the vaccines have met a rigorous set of criteria and have been proven to be effective based on data by the vaccine manufacturers and large clinical trials. The federal government has determined that the vaccine is safe and recommends their use to prevent the spread of COVID-19. If you’d like more information about EUA, watch the Food and Drug Administration’s explanatory video and/or review the FDA’s infographic about the path of a COVID-19 vaccine from research to EUA. THE CDC has also published guidance about the safety of the COVID-19 vaccines.

 

Is there a difference between the Pfizer, Moderna, or J&J vaccines?

The Pfizer, Moderna, and J&J vaccines are authorized and recommended by the FDA to protect against COVID-19. The Pfizer and Moderna vaccines are both mRNA vaccines, but the Pfizer and Moderna vaccines have different ingredients, need to be stored at different temperatures, and the second dose is given at different time intervals. The Pfizer vaccine is given in 2 shots, at least 21 days apart. The Moderna vaccine is given in 2 shots, at least 28 days apart.

The J&J vaccine is a viral vector vaccine that contains a piece of the harmless adenovirus type 26 virus. It is given in 1 shot.

Additionally, the Pfizer vaccine is authorized for individuals 16 years of age and older, but the Moderna and J&J vaccines are only authorized for individuals who are at least 18 years old.

They have very similar efficacy, side effects, and safety profile.

For more information, please visit the FDA’s fact sheet for each vaccine: Pfizer, Moderna, or J&J.

 

Why do I need two shots for the Pfizer or Moderna vaccines?

Currently, the Pfizer and Moderna vaccines require 2 shots to give you the most protection against COVID-19. The Pfizer vaccine is given in 2 shots, at least 21 days apart. The Moderna vaccine is given in 2 shots, at least 28 days apart.

 

Can I get multiple types of vaccines?

No, the vaccines are NOT interchangeable. If your first dose is the Pfizer vaccine, your second dose must also be the Pfizer vaccine. Similarly, if your first dose is the Moderna vaccine, your second dose must also be the Moderna vaccine. If you get the J&J vaccine, you should not get a Pfizer or Moderna vaccine.

 

I have allergies that prevent me from taking certain vaccines. What’s in the COVID-19 vaccines?

The COVID-19 vaccines do not contain eggs, preservatives, or latex. For a full list of ingredients, please visit the FDA’s fact sheet for each vaccine: Pfizer; Moderna; or J&J. The CDC has also published guidance about the COVID-19 vaccines and allergic reactions.

In general, unless you are allergic to a specific ingredient in the COVID-19 vaccines or had an allergic reaction to the first dose of the vaccine, you can likely be vaccinated safely. AEO encourages you to discuss your options with your health care providers.

 

Can I take a COVID-19 vaccine if I’m already pregnant or breastfeeding?

The FDA has explained that the vaccine has not been determined to be unsafe for pregnant or breastfeeding individuals based on available information. The COVID-19 vaccine trials did not deliberately include pregnant or breastfeeding individuals, however some vaccine trial participants inadvertently became pregnant and received the vaccine. The CDC has published vaccination considerations for individuals who are pregnant or breastfeeding.

Ovia Health has also published guidance for pregnant people, as well as guidance for parents. AEO encourages you to speak with your health care provider.

 

I have a medical condition. How will I know if I can take the vaccine?

The CDC has published general vaccination considerations for individuals with certain underlying medical conditions.

Depending on your underlying medical condition, your health care provider may explain that it may be even more important to get the vaccine as you could be at risk for a more severe case if you contract COVID-19.

We encourage you to speak with your health care provider about your specific circumstances before taking the vaccine.

 

I already had COVID-19. Should I still get the vaccine?

Yes. Because there’s still a risk that you can get re-infected with COVID-19, you are still encouraged to get the vaccine even if you have already recovered from COVID-19.

 

Are there any side effects of the vaccine?

According to the FDA, the most commonly reported side effects for the Pfizer vaccine are: pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, and fever.

The side effects most commonly reported for the Moderna vaccine are: pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, swollen lymph nodes in the same arm as the injection, nausea and vomiting, and fever. During the drug trials, more people experienced these side effects after the second dose than after the first dose.

The most commonly reported side effects for the J&J vaccine are: pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects occurred within 1-2 days following vaccination and were mild to moderate in severity and lasted 1-2 days.

The CDC has published information about what to expect after getting a COVID-19 vaccine and tips for dealing with side effects here.

 

Can I still get COVID-19 after I receive a vaccine?

It is possible. You have approximately 50% immunity about a week or two after receiving the first dose of the Pfizer or Moderna vaccines. The immunity increases to approximately 94% to 95% in the weeks after receiving the second dose.

With respect to the J&J vaccine, it is approximately 67% effective in preventing moderate to severe/critical COVID-19 disease occurring at least 14 days after vaccination and 66% effective in preventing moderate to severe/critical disease at least 28 days after vaccination.

 

Do I still need to wear a mask at work after I get my vaccine?

Yes, you will continue to have to follow AEO’s safety protocols, including wearing a mask, washing your hands often, and social distancing when possible.  The CDC and medical professionals are not yet certain if individuals who received the vaccine can still transmit COVID-19 to another person. As we continue to receive more information, AEO will continue to evaluate its policies and protocols.

 

Where can I get more information about the vaccines?

The FDA has published FAQs (Pfizer; Moderna; J&J) and fact sheets (Pfizer; Moderna; J&J) for each vaccine. The CDC has also published guidance and FAQs about the COVID-19 vaccines. AEO also encourages you to speak with your primary care physician about the COVID-19 vaccine.

The Public Health Agency of Canada has also published information about the COVID-19 vaccines.

Testing Requirements For Non-Vaccinated Travelers

NOTE: In accordance with CDC guidance, you do not need these testing requirements if at least 2 weeks have passed since your second Moderna or Pfizer vaccine, or your J&J Vaccine.

In accordance with state guidance, associates traveling domestically are no longer required to quarantine after traveling out-of-state unless they begin to experience COVID-19 symptoms. Associates should continue to monitor themselves for symptoms after domestic travel.

If an associate travels internationally or experiences any symptoms of COVID-19 after traveling domestically, the associate must quarantine for at least 10 days or go through the test-out procedure.

If an associate wishes to test out of the 10-day quarantine, the associate must:

• Quarantine for at least 3 days upon their arrival to their home state

• Receive a negative COVID-19 test result on or after day 4 of quarantine, and be symptom-free to exit quarantine.

If an associate chooses to take advantage of the test-out procedure, a PCR test is referred but rapid antigen tests are acceptable. For more information about COVID-19 testing, please visit the website of your state or territorial health department.

• California
• Iowa
• Kansas
• Pennsylvania
• New York

For information on testing options offered through AEO’s medical insurance, including details on ordering an at-home testing kit, click here.

Full-vaccinated Associate Travel Guidance
Associates who are fully vaccinated, do not need to quarantine after travel domestically and internationally.

• Fully vaccinated associates do not need to get tested before or after travel unless their destination requires it.
• Fully vaccinated associates do not need to self-quarantine upon their return unless they begin to experience symptoms of COVID-19.

Fully vaccinated associates should still follow CDC’s recommendations for traveling safely including:

• Wear a mask over your nose and mouth
• Stay 6 feet from others and avoid crowds
• Wash your hands often or use hand sanitizer

Below is a list of frequently asked questions, including general examples. If you have a more specific question not found below, please contact your supervisor or HRBP.

Can associates be informed when positive tests are identified? If I know that there have been positive tests, I would feel more inclined to take it upon myself to be tested if I experience symptoms that could otherwise be identified as cold/flu.

If an associate were to test positive, we will proceed with our contact tracing procedure. You will be notified if the Company is informed that you may have been in “close contact” with the COVID-19 positive associate. In general, this means, if you were in close contact and less than 6 feet apart for a cumulative amount of time of 15 minutes or longer during any 24-hour period with the associate 2 days prior to the individual’s first symptoms and up until their last day worked. However, the definition of close contact may vary in accordance with state/provincial and local law.

What is the difference between isolation and quarantine?

In accordance with CDC guidance, “quarantine” is for people who may have been in “close contact” with someone who has tested positive for COVID-19. These individuals should quarantine for 10 days from the last date of close contact or exposure to see if they begin having symptoms.  This helps prevent the spread that can occur before a person knows they are sick or if they are infected with the virus without feeling symptoms.

Currently, “close contact” is defined as being within 6 feet of a COVID-19 positive individual, unmasked, for at least 15 minutes in a 24 hour period. “Exposure” includes intimate family contact or contact with the respiratory droplets of an individual who is known to have tested positive for COVID-19 or is presumed to be COVID-19 positive based on their symptoms.

“Isolation” is for people who have symptoms of COVID-19 or receive a positive COVID-19 diagnosis.  These individuals should not come in contact with other people for 10 days from symptom onset or their test date.  The current CDC recommendation is to isolate for at least 10 days since symptoms first appeared and at least 24-hours with no fever without fever-reducing medication and other symptoms of COVID-19 are improving. Loss of taste and smell may persist for weeks or month after recovery and need not delay the end of isolation.

If you have been told to quarantine or are isolating after having tested positive for COVID-19, please contact your supervisor or HRBP.

I think I may have worked with someone who tested positive. Will the Company share their name so I can confirm if I am at risk?

We will not share the name of the associate who tested positive for COVID-19 due to privacy laws but will follow our contact tracing procedures. The HR team will contact anyone who has been identified as having been in close contact with an associate who tests positive. In general, this means, if you were in close contact and less than 6 feet apart for a cumulative amount of time of 15 minutes or longer during any 24-hour period with the associate 2 days prior to the individual’s first symptoms and up until their last day worked. However, the definition of close contact may vary in accordance with state/provincial and local law. If you or anyone from your team starts exhibiting symptoms, please self-quarantine and contact your supervisor and HRBP during your self-quarantine.

For those who come in close contact with an individual who tests positive for COVID-19, what does the definition of a “10 day self-quarantine from all daily activities” mean?

Quarantine is used to keep someone who has been in close contact with an individual who tested positive for  COVID-19 away from others. Quarantine helps prevent spread of disease that can occur before a person knows they are sick or if they are infected with the virus without feeling symptoms. People in quarantine should stay home, separate themselves from others, monitor their health, and follow directions from their state or local health department.

Following exposure to someone who is COVID-19 positive, how long will it take for my COVID-19 test to be positive if I have contracted the virus?

The amount of time to become positive depends on the test and the person.  There is not a clear cut number of days that you need to wait to see if you are positive.  Most people will test positive a week after being exposed, but there are certainly cases that are longer.  The closer you are tested to the date of the possible exposure, the less likely the test will be positive (even if you contracted COVID-19).

Who should I inform that I may have been exposed to a person who tested positive for COVID-19?

Please follow our internal reporting procedures and contact your supervisor and HRBP.

If you, or someone who resides in your home, is diagnosed with COVID-19 please call 1-877-322-0236 to report the diagnosis to the Global Asset Protection team.

We are currently following the CDC guidelines that if you believe you have been exposed to COVID-19 and are currently exhibiting symptoms, you should first inform your healthcare provider and tell them about your symptoms and exposure. Your healthcare provider can then advise on proper medical care and appropriate next steps, including anyone to inform of your potential exposure. If you think you have been exposed to COVID-19 and are exhibiting signs and symptoms, you can find additional CDC recommendations here.

If you are not experiencing signs and symptoms of illness, we are taking guidance from the CDC that you continue to practice social-distancing and monitor for any future symptoms of COVID-19. If you may have come in close contact with someone who has COVID-19 but are not exhibiting symptoms, please follow the CDC instructions on how to protect yourself and your family here.

I’ve been exposed to COVID-19 and need to quarantine. Is there a way I can shorten the 10-day quarantine period?

Yes. If you go the first 7 days without any symptoms and between days 5-7 you take a COVID-19 test and receive a negative result. However, the quarantine cannot end earlier than day 7 if you are quarantining based on exposure due to a COVID-19 individual.

In order to take advantage of these shorter quarantine options you must still follow the criteria below:

• You must not have exhibited COVID-19 symptoms during the shortened quarantine period.
• You must continue to monitor themselves for symptoms for the remainder of the 10-day self-quarantine period.
• You must strictly adhere to mitigation strategies after exiting self-quarantine – g., mask use, social distancing, avoiding crowds, etc.

A co-worker has a persistent cough and/or is exhibiting signs of a respiratory illness.  Will AEO ask this associate to go home as a precautionary measure?

Yes. AEO has consistently said (not only this year, but during previous cold and flu seasons) that associates who are sick (whether it be from a common cold, flu, or other virus) should stay home and return to work only when they are not contagious and are feeling better.

Consistent with this approach, the CDC advises employees “who have symptoms of acute respiratory illness . . . to stay home and not come to work until they are free of fever (100.4° F [37.8° C] or greater using an oral thermometer), signs of a fever, and any other symptoms for at least 24 hours, without the use of fever-reducing or other symptom-altering medicines (e.g. cough suppressants).”

If I am asked to go home because I am exhibiting symptoms of a respiratory illness, will I be required to produce a doctor’s note before coming back to work?

Any associate that is sick (whether it be from a common cold, flu, or other virus) should stay home and only return to work only when they are not contagious and are feeling better. A doctor’s note is not needed.

If you have received a positive COVID-19 test result and have remained out of work for at least 10 days, a doctor’s note is required to return to the workplace.

What is AEO doing to disinfect and clean the workplace?

AEO has taken a number of steps to ensure our facilities are being thoroughly cleaned. This includes increased cleaning of touchpoints, hard surfaces, cafés, kitchens and restrooms throughout the day and nightly.  Additional hand-sanitizers, disinfectant spray and masks are also being provided for use by associates.

We are asking all associates to make sure they are maintaining high-standards of hygiene, including washing hands and properly cleaning.   We are also continuing to evaluate and develop additional cleaning protocols.

I was told those at higher risk should avoid travel on commercial airlines. Who is at higher risk?

Some people are at higher risk of getting very sick from this illness. This includes, but is not limited to:

• Older adults
• Smokers
• People who have serious chronic medical conditions like:
  • Heart disease
  • Diabetes
  • Lung disease
  • Obesity
  • An immune compromised state
  • Chronic Kidney Disease

If you are at higher risk for serious illness from COVID-19 because of your age or because you have a serious long-term health problem, it is extra important for you to take actions to reduce your risk of getting sick with the disease. More information from the CDC can be found here.

I’ve been working from home because of COVID-19. Is there any guidance on what types of expenses can be reimbursed?

Yes, the Work From Home Support Policy outlines what type of expenses are reimbursable for associates who are working from home because of COVID-19. If you have any additional questions, please contact your supervisor or HRBP.

City of Pittsburgh COVID-19 Temporary Emergency Paid Sick Leave FAQs

I had absences related to COVID-19 earlier this year. Can this Pittsburgh COVID-19 Temporary Emergency Paid Sick Leave be applied to my absences?

Pittsburgh COVID-19 Temporary Emergency Paid Sick Leave (“EPSL”) became effective on December 9, 2020. You may use this leave for any days missed on or after December 9th, 2020, for an eligible reason (explained below). However, the leave cannot be applied to any COVID-related absence before the law went into effect. Because your absences were before the effective date, they would not qualify EPSL. If you have questions whether other designations are available, such as FMLA, STD, PTO, or Pittsburgh Paid Sick Leave, please contact the Benefits department at corploa@ae.com.

I’m a full-time corporate associate, why do I only get PTO and EPSL (not Pittsburgh Paid Sick Leave)?

AEO offers Paid Time Off (PTO) benefits in excess of the time offered by the Pittsburgh Paid Sick Leave law. Additionally, PTO covers not only absences for personal reasons and vacations but also absences due to things such as illness. As a result, Pittsburgh’s Paid Sick Leave time was absorbed into the PTO Policy for corporate associates, but EPSL remains a separate benefit. Unlike PTO, EPSL does not accrue and is not paid out upon separation from AEO.

I took time off after December 9, 2020. Why was my PTO used instead of EPSL?

AEO will not assume you want to use your EPSL leave. If you wish to use your EPSL leave, instead of your PTO or Paid Sick Leave (if applicable), please communicate this to Benefits at corploa@ae.com.

What proof do I need to need to establish I qualify for EPSL?

At this time, AEO does not require a doctor’s note to establish eligibility for EPSL. However, AEO reserves the right to ask for further information or supporting documents in the event questions about eligibility arise. AEO trusts that associates seeking EPSL leave will make truthful representations as required by AEO policy, including but not limited to the Code of Ethics.

I think I may have been exposed to COVID-19 but I’m not sure. My coworker Jane’s son just tested positive for COVID-19. Jane is not experiencing any symptoms, but her doctor advised her to quarantine for 14 days. The day before she was advised to quarantine, I sat in the same room as Jane for more than 15 minutes. We were both masked and no one has told me I need to quarantine. Do I qualify for EPSL?

The EPSL is only available for the following limited scenarios:

• You have been told by a public health official, a local health official, a health care provider, or AEO that you can’t come to work because you were exposed to COVID-19 or are because you are experiencing symptoms; OR
• You or your family member have been told to self-isolate after being diagnosed with COVID-19 or experiencing COVID-19 symptoms; OR
• You or your family member are seeking medical treatment, diagnosis, or care of COVID-related symptoms.

Because your situation does not currently fall within one of these scenarios, you would not be eligible to take EPSL at this time. However, that may change if you are contacted by HR if it is determined that you were in close-contact with an individual who tested positive for COVID-19. Remember, HR will not be able to share the name of the associate who tested positive for COVID-19 due to privacy concerns.

I can’t work remotely due to the nature of my job. I haven’t been exposed to COVID-19, I don’t need to take care of my family member, no one has told me it is unsafe for me to be work, and I am not experiencing symptoms – but I just don’t feel comfortable coming into my workplace because of the rise in COVID-19 cases. Can I use EPSL to take time off?

Because your situation does not fall within one of the EPSL qualifying scenarios explained above, you would not be eligible to take EPSL in this scenario. However, if you have specific concerns about your situation, please reach out to Benefits at corploa@ae.com to discuss your options.

How should I record my EPSL time? 

Once your EPSL is approved, please leave your timecard blank and send all hours missed to corploa@ae.com. Benefits will be sending bi-weekly updates to Payroll to ensure you are paid for your EPSL.

We encourage associates to take a common-sense approach to proactive measures. As always during cold and flu season, if you develop flu-like symptoms (fever, cough, shortness of breath), please do not go to the office and work from home until the symptoms are gone.  In light of the coronavirus outbreak, Global Asset Protection presents the following resources for our associates.

World Health Organization (WHO) Coronavirus Disease (COVID-19): WHO’s pages and resources on the virus, primarily for the public and health professionals.

U.S. Centers for Disease Control and Infection (CDC) 2019 Novel Coronavirus: CDC’s pages and resources on the virus, primarily geared to a U.S. audience, including resources geared toward businesses, travel, health professionals, laboratories, and the public.

Interim Guidance for Businesses and Employers to Plan and Respond to Coronavirus Disease 2019: Guidance from the CDC designed to help prevent workplace exposures to acute respiratory illnesses, including nCoV, in non-healthcare settings. The guidance also provides planning considerations if there are more widespread, community outbreaks of COVID-19.

OSAC Travel Tips: Coronavirus: The U.S. Department of State’s Overseas Security Advisory Council (OSAC) offers tips to stay healthy when travelling abroad.

2019 Novel Coronavirus Hazardous Information Training Sheet (HITS): Developed by the U.S. Department of Homeland Security’s Federal Protective Service, this HITS provides information on the evolving Coronavirus and tips for workforce protection and readiness.

Johns Hopkins Center for Systems Science and Engineering Coronavirus Map and Information: Presents a heat map of worldwide infections and the latest statistics of confirmed cases, fatalities, and recoveries.

• Field Associates: For any additional questions, email a member of your HR Team at FieldHRCommunication@ae.com or call +1-724-779-5200 or +1-844-230-2855 (toll free). To best support you, please be sure to provide your employee ID with your inquiry.
• Corporate Associates: For any additional questions, contact your designated HRBP or email HRQuestion@ae.com.
• Distribution Center Associates: For additional questions, contact a member of your local HR team.

• Furlough FAQs- Stores and Corporate
• Furlough FAQs- Stores and Corporate- Spanish
• Unemployment Websites by State
• Essential Information When Filing an Unemployment Claim
• IRS Form-14039 Identity Theft Affidavit
• Massachusetts Unemployment Form

• Employment Insurance Information
• Canada Recover Benefits (CRB) Information
• Canada Recovery Sick Benefit (CRSB) Information
• Canada Recovery Caregiving Benefit (CRCB) Information
• Temporary Layoff Letter- Nova Scotia (May 2021)
• Temporary Layoff Letter – Ontario (April 2021)
• Temporary Layoff Letter- Newfoundland (March 2021)
• Temporary Layoff Letter – Ontario (January 2021)
• Temporary Layoff Letter – Quebec (January 2021)
• Temporary Layoff Letter- York & Windsor (Dec. 2020)
• Temporary Layoff Letter- Manitoba & Ontario (Nov. 2020)
• Temporary Layoff Letter- Stores & Corporate (April 2020) (Note: individual letters may differ by province)
• COVID -19 Store Exposure Control Plan (Canada)
• Government of Canada COVID19 Site
  • Alberta COVID19 Site
  • British Columbia COVID19 Site
  • Ontario COVID19 Site
  • Saskatchewan COVID19 Site
  • Quebec COVID19 Site
  • Newfoundland COVID19 Site
• Government of Canada COVID19 and Provincial Travel Information
• Temporary Layoff FAQs- Stores & Corporate

• Benefits Directory
• Mental Well-Being Resources for All Associates
• Mental Well-Being Resources for Medically Enrolled Associates – LifeWorks English
• Lifeworks COVID19 Support
• Mental Well-Being Resources for Medically Enrolled Associates – LifeWorks French
• Tips for Coping with COVID-19
• Canada Vacation Time Policy

For additional support, reach out to a member of our benefits team:

•  Email CanadianBenefits@ae.com or by phone at 289-562-8077
• Distribution Center Associates: For any additional questions, contact a member of your local HR Team.

• Temporary Layoff FAQs- Stores & Corporate
• Employment Insurance Information
• Temporary Layoff Letter- Stores & Corporate
• COVID -19 Store Exposure Control Plan (Canada) FINAL_FR-CA
• Temporary Layoff Letter – Quebec (January 2021)

• Recursos Útiles Para El Bienestar Mental Disponibles Para Todos Los Asociados
• Formato Solicitud de Reclamación GMM
• Informe Medico
• INSTP Cobertura Padecimiento por COVID-19
• Instrucciones para el Formato de Beneficiarios para Seguro de Vida
• Aplicación para el IMSS
• Apoyo Emotional Te Queremos Ayudar
• Formato de Beneficiarios del Seguro Vida
• Presentación de Gympass W
• Instrucciones para Acceso a GympassW
• COVID -19 Store Exposure Control Plan
• COVID -19 Store Exposure Control Plan (Spanish)